ELVAF
Price
$0.90
Change
-$0.05 (-5.26%)
Updated
Nov 8 closing price
WXIBF
Price
$1.90
Change
-$0.60 (-24.00%)
Updated
Dec 17 closing price
Ad is loading...

ELVAF vs WXIBF

Header iconELVAF vs WXIBF Comparison
Open Charts ELVAF vs WXIBFBanner chart's image
Evolva Holding AG
Price$0.90
Change-$0.05 (-5.26%)
Volume$194
CapitalizationN/A
Wuxi Biologics Cayman
Price$1.90
Change-$0.60 (-24.00%)
Volume$8.25K
CapitalizationN/A
ELVAF vs WXIBF Comparison Chart
Loading...
ELVAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVAF vs. WXIBF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVAF is a Hold and WXIBF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ELVAF: $0.90 vs. WXIBF: $1.90)
Brand notoriety: ELVAF and WXIBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVAF: 117% vs. WXIBF: 10%
Market capitalization -- ELVAF: $7.26M vs. WXIBF: $8.89B
ELVAF [@Biotechnology] is valued at $7.26M. WXIBF’s [@Biotechnology] market capitalization is $8.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVAF’s FA Score shows that 1 FA rating(s) are green whileWXIBF’s FA Score has 1 green FA rating(s).

  • ELVAF’s FA Score: 1 green, 4 red.
  • WXIBF’s FA Score: 1 green, 4 red.
According to our system of comparison, WXIBF is a better buy in the long-term than ELVAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVAF’s TA Score shows that 2 TA indicator(s) are bullish while WXIBF’s TA Score has 4 bullish TA indicator(s).

  • ELVAF’s TA Score: 2 bullish, 1 bearish.
  • WXIBF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ELVAF is a better buy in the short-term than WXIBF.

Price Growth

ELVAF (@Biotechnology) experienced а 0.00% price change this week, while WXIBF (@Biotechnology) price change was -24.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXIBF($8.89B) has a higher market cap than ELVAF($6.8M). ELVAF YTD gains are higher at: 5.202 vs. WXIBF (-48.787). WXIBF has higher annual earnings (EBITDA): 5.5B vs. ELVAF (-86.01M). WXIBF has higher revenues than ELVAF: WXIBF (17B) vs ELVAF (11.9M).
ELVAFWXIBFELVAF / WXIBF
Capitalization6.8M8.89B0%
EBITDA-86.01M5.5B-2%
Gain YTD5.202-48.787-11%
P/E RatioN/A23.07-
Revenue11.9M17B0%
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ELVAF vs WXIBF: Fundamental Ratings
ELVAF
WXIBF
OUTLOOK RATING
1..100
3641
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9844
PRICE GROWTH RATING
1..100
5936
P/E GROWTH RATING
1..100
10020
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELVAF's Valuation (17) in the null industry is somewhat better than the same rating for WXIBF (65). This means that ELVAF’s stock grew somewhat faster than WXIBF’s over the last 12 months.

ELVAF's Profit vs Risk Rating (100) in the null industry is in the same range as WXIBF (100). This means that ELVAF’s stock grew similarly to WXIBF’s over the last 12 months.

WXIBF's SMR Rating (44) in the null industry is somewhat better than the same rating for ELVAF (98). This means that WXIBF’s stock grew somewhat faster than ELVAF’s over the last 12 months.

WXIBF's Price Growth Rating (36) in the null industry is in the same range as ELVAF (59). This means that WXIBF’s stock grew similarly to ELVAF’s over the last 12 months.

WXIBF's P/E Growth Rating (20) in the null industry is significantly better than the same rating for ELVAF (100). This means that WXIBF’s stock grew significantly faster than ELVAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELVAFWXIBF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
41%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
40%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
ELVAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGSEX61.95N/A
N/A
AMG Veritas Asia Pacific N
VWNFX49.71-0.38
-0.76%
Vanguard Windsor™ II Inv
IRMAX11.00-0.09
-0.81%
Voya Russell Mid Cap Index Port A
BRSBX14.67-0.16
-1.08%
MFS Blended Research Small Cap Eq B
FWAFX35.34-0.39
-1.09%
Fidelity Advisor Worldwide A

ELVAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVAF has been loosely correlated with REPL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVAF jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVAF
1D Price
Change %
ELVAF100%
N/A
REPL - ELVAF
60%
Loosely correlated
-6.09%
CLYYF - ELVAF
47%
Loosely correlated
N/A
IBIO - ELVAF
39%
Loosely correlated
+2.98%
GLABF - ELVAF
34%
Loosely correlated
-7.29%
NRSN - ELVAF
24%
Poorly correlated
+23.35%
More

WXIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXIBF has been loosely correlated with WXXWY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXIBF jumps, then WXXWY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXIBF
1D Price
Change %
WXIBF100%
-24.00%
WXXWY - WXIBF
46%
Loosely correlated
-0.99%
JAGX - WXIBF
22%
Poorly correlated
+2.62%
NVAX - WXIBF
21%
Poorly correlated
-2.49%
ELVAF - WXIBF
21%
Poorly correlated
N/A
EVAX - WXIBF
20%
Poorly correlated
-8.92%
More